The
Wilmer Eye Institute
at Johns Hopkins University
School of Medicine
What’s New
in Diabetic
Retinopathy
and Venous Occl...
DESCRIPTION
The total number of people worldwide with diabetes mellitus is projected
to rise from 171 million in 2000 to 3...
What’s New in Diabetic Retinopathy and Venous Occlusive Disease	
Guest Speakers
Mary Beth Aronow, MD
Clinical Fellow
Natio...
Friday, October 11, 2013
HOTEL RESERVATION CUT-OFF DATE: SEPTEMBER 20, 2013
A limited block of sleeping rooms has been res...
Upcoming SlideShare
Loading in …5
×

What's New In Diabetic Retinopathy and Venous Occlusive Disease

375 views

Published on

Published in: Health & Medicine, Education
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
375
On SlideShare
0
From Embeds
0
Number of Embeds
6
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

What's New In Diabetic Retinopathy and Venous Occlusive Disease

  1. 1. The Wilmer Eye Institute at Johns Hopkins University School of Medicine What’s New in Diabetic Retinopathy and Venous Occlusive Disease October 11, 2013 Thomas B. Turner Building Johns Hopkins University School of Medicine Baltimore, Maryland Presented by Department of Ophthalmology THE RETINA DIVISION What’sNewinDiabeticRetinopathyandVenousOcclusiveDisease October11,2013 Baltimore,Maryland Non-ProfitOrg. U.S.Postage PAID Baltimore,MD PermitNo. 5839 DatedMaterial OfficeofContinuingMedicalEducation Turner20 720RutlandAvenue Baltimore,Maryland21205-2195 C O N T I N U I N G M E D I C A L E D U C A T I O N
  2. 2. DESCRIPTION The total number of people worldwide with diabetes mellitus is projected to rise from 171 million in 2000 to 366 million in 2030. In the United States, almost 24 million or 8 percent of the population has diabetes mellitus. Approximately 4.0 million Americans age 40 and older have diabetic retinopathy, 900,000 of whom have vision threatening disease, defined as pre-proliferative retinopathy, macular edema, or both. Diabetic retinopathy remains the leading cause of blindness in adults who make up the work force. Despite this, diabetic retinopathy and venous occlusive disease are often under-diagnosed and under-treated. This annual course highlights new information being reported by the Diabetic Retinopathy Clinical Research Network and others, which will impact current standard care and management strategies. WHO SHOULD ATTEND This activity is intended for ophthalmologists, retinal specialists, residents, fellows and other health care professionals. OBJECTIVES After attending this activity, the participant will demonstrate the ability to: •  Summarize evidence of relation of diabetic control to incidence and severity of retinopathy. •  Diagnose diabetic macular edema, severe non-proliferative retinopathy, and high risk proliferative diabetic retinopathy. •  Determine how best to manage diabetic macular edema, severe non- proliferative diabetic retinopathy, and high risk proliferative diabetic retinopathy. •  Recognize new experimental treatment options. Program  •  Friday, October 11, 2013 7:30 - 7:55 Registration, Continental Breakfast and Exhibits 7:55 - 8:00 Welcome and Introduction Peter McDonnell, MD 8:00 - 8:05 Conference Goals Sharon Solomon, MD Epidemiology and Medical Management Moderator: Sharon Solomon, MD 8:05 - 8:20 Epidemiology of Diabetic Retinopathy and Retinal Vein Occlusions Ann-Margaret Ervin, PhD, MPH 8:20 - 8:40 An Ophthalmologist’s Guide to Diabetes Medical Management in 2013 Rita Kalyani, MD 8:40 - 9:00 Screening Strategies and Challenges for Health Care Providers Other than Ophthalmologists Sherita Hill Golden, MD, MHS 9:00 - 9:20 Fibrate Treatment of High Triglycerides Improves Diabetic Retinopathy? Emily Chew, MD 9:20 - 9:40 The Metabolic Syndrome and the Prevention of Diabetes Simeon Margolis, MD, PhD 9:40 - 10:00 Update on Classification of Diabetic Retinopathy Susan Bressler, MD 10:00 - 10:10 Questions and Discussion 10:10 - 10:30 Refreshment Break and Exhibits Management of Diabetic Macular Edema Moderator: Susan Bressler, MD 10:30 - 10:50 Aflibercept, Bevacizumab, and Ranibizumab Trials for Diabetic Macular Edema Alexander Brucker, MD 10:50 - 11:10 Retreatment Algorithms: What to Consider after Starting Anti-VEGF Therapy Neil Bressler, MD 11:10 - 11:30 Is There a Role for Corticosteroids for Diabetic Macular Edema? Peter Campochiaro, MD 11:30 - 11:45 What Role Does Genetics Have in Diabetic Retinopathy? Hendrik Scholl, MD 11:45 - 12:30 Managing Diabetic Macular Edema in 2013: Case Presentations Moderator: Sharon Solomon, MD Discussants: Alexander Brucker, MD; Susan Bressler, MD; Michael Elman, MD; Peter Campochiaro, MD 12:30 - 1:30 Lunch with Retina Faculty Management of Proliferative Diabetic Retinopathy Moderator: Adam Wenick, MD, PhD 1:30 - 1:45 Impact of Intravitreal Corticosteroids or Anti-VEGF Drugs on Worsening or Improvement of Diabetic Retinopathy? Mary Beth Aronow, MD 1:45 - 2:00 Lessons on PRP from the Diabetic Retinopathy Clinical Research Network Adam Wenick, MD, PhD 2:00 - 2:15 Vitrectomy for Proliferative Diabetic Retinopathy Peter Gehlbach, MD, PhD 2:15 - 2:40 Surgical Case Presentations Moderator: Adrienne Scott, MD Discussants: Peter Gehlbach, MD, PhD; Akrit Sodhi, MD, PhD; Adam Wenick, MD, PhD Management of Retinal Vein Occlusions Moderator: Mary Beth Aronow, MD 2:40 - 3:00 Anti-VEGF Drugs or Corticosteroids for Macular Edema from Retinal Vein Occlusion? Michael Elman, MD 3:00 - 3:20 Refreshment Break and Exhibits 3:20 - 3:35 Why Isn’t a Medical Work-up Indicated for Venous Occlusive Disease? Howard Ying, MD, PhD 3:35 - 3:50 Role of Laser Photocoagulation for Macular Edema from Branch Retinal Vein Occlusion Daniel Finkelstein, MD 3:50 - 4:05 Management of Capillary Non-Perfusion and Neovascularization Following Retinal Vein Occlusion Akrit Sodhi, MD, PhD 4:05 - 4:35 Managing Retinal Vein Occlusions in 2013: Case Presentations Moderator: Neil Bressler, MD Discussants: Howard Ying, MD, PhD; Sharon Solomon, MD; Daniel Finkelstein, MD 4:35 - 4:40 Closing Remarks Sharon Solomon, MD 4:40 Adjourn Please complete and return the Evaluation and Credit Report Forms. The Registration Desk will remain open during conference hours. The Johns Hopkins University School of takes responsibility for the content, quality and scientific integrity of this CME activity. This schedule is subject to change. Accreditation Statement The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Credit Designation Statement The Johns Hopkins University School of Medicine designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Policy on Speaker and Provider Disclosure It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.
  3. 3. What’s New in Diabetic Retinopathy and Venous Occlusive Disease Guest Speakers Mary Beth Aronow, MD Clinical Fellow National Institute of Health Bethesda, Maryland Alexander Brucker, MD Professor of Ophthalmology Chief, Retina and Vitreous Service Scheie Eye Institute Philadelphia, Pennsylvania Emily Chew, MD Deputy Director Division of Epidemiology and Clinical Research National Eye Institute Bethesda, Maryland Michael Elman, MD Assistant Professor of Ophthalmology Elman Retina Group Baltimore, Maryland Activity Director Sharon Solomon, MD Katharine M. Graham Professorship Associate Professor of Ophthalmology Activity Co-Director Neil Bressler, MD James P. Gills Professor of Ophthalmology Chief, Retina Division Speakers General Information Registration Friday, October 11 7:30-7:55 a.m. Location Thomas B. Turner Building Johns Hopkins University School of Medicine 720 Rutland Avenue Baltimore, Maryland 21205 The Turner Building is located on Rutland Avenue at Monument Street. Directions and campus parking information are available on our website under the contact and travel section at www.HopkinsCME.edu. Handicapped parking is available in the nearby Rutland Garage. Complimentary round-trip transportation for attendees staying at conference headquarters hotel will be provided. Johns Hopkins is smoke- free. Fees REGISTRATION CUT-OFF DATE: October 4, 2013 Methods of Payment: Payment by check or credit card must accompany the registration form prior to the activity. On-site payments by credit card only. Foreign payments must be by credit card or with a U.S. Dollar World Money Order. The registration fee includes instructional materials, continental breakfast, refreshment breaks and lunch. Early Bird On or Before September 3 Physicians/Allied Health Professionals.................................................... $275 Residents*/Fellows*................................................................................. $175 After September 3 Physicians/Allied Health Professionals.................................................... $325 Residents*/Fellows*................................................................................. $225 *with verification of status You will receive a confirmation by e-mail if you have provided your e-mail address. Otherwise confirmation will be sent by mail. If you have not received it by October 4, 2013, call (410) 502-9635 to confirm that you are registered. A certificate of attendance will be sent by November 22, 2013 to the e-mail address you provide on the registration form. The Johns Hopkins University reserves the right to cancel or postpone any activity due to unforeseen circumstances. In this event, the University will refund the registration fee but is not responsible for travel expenses. Additionally, we reserve the right to change the venue to a comparable venue. Under such circumstances registrants will be notified as soon as possible. Late Fee and Refund Policy A $50 late fee applies to registrations received after 5:00 p.m. EST on October 4, 2013. A handling fee of $50 will be deducted for cancellation. An additional fee may apply for cancellation of other events, including workshops and social activities. Refund requests must be received by fax or mail by October 4, 2013. No refunds will be made thereafter. Transfer of registration to another Johns Hopkins conference in lieu of cancellation is not possible. Hotel and Travel Information We strongly encourage you to book your accommodations at the Hyatt Regency Baltimore, which is the conference headquarters hotel. The Johns Hopkins Office of CME makes every effort to secure the best rate for overnight accommodations. The rate is part of a negotiated conference package that incorporates many services. By staying at the host hotel and booking within the room block, you help us maintain current conference benefits and keep future registration fees reasonable. Please consider this when making your overnight accommodations decision. Johns Hopkins Speakers Susan Bressler, MD Julia G. Levy, PhD Professor of Ophthalmology Peter Campochiaro, MD George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience Ann-Margaret Ervin, PhD, MPH Assistant Scientist Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Daniel Finkelstein, MD Professor of Ophthalmology Peter Gehlbach, MD, PhD Associate Professor of Ophthalmology Sherita Hill Golden, MD, MHS Hugh P. McCormick Family Associate Professor of Medicine and Epidemiology Rita Kalyani, MD Assistant Professor of Medicine Division of Endocrinology Simeon Margolis, MD, PhD Professor of Medicine and of Biological Chemistry Peter McDonnell, MD Professor and Chairman of Ophthalmology Hendrik Scholl, MD Dr. Frieda Derdeyn Bambas Professor of Ophthalmology Adrienne Scott, MD Assistant Professor of Ophthalmology Akrit Sodhi, MD, PhD Assistant Professor of Ophthalmology Adam Wenick, MD, PhD Assistant Professor of Ophthalmology Howard Ying, MD, PhD Assistant Professor of Ophthalmology
  4. 4. Friday, October 11, 2013 HOTEL RESERVATION CUT-OFF DATE: SEPTEMBER 20, 2013 A limited block of sleeping rooms has been reserved for your convenience and will be available on a first-come, first-served basis. Hyatt Regency Baltimore (800) 233-1234 300 Light Street (410) 528-1234 Baltimore, Maryland 21202 FAX: (410) 605-2870 Web Site: www.baltimore.hyatt.com The Hyatt Regency Baltimore, centrally located on the Inner Harbor and an industry leader since its opening, holds the longest four-diamond award status in the state with beautiful guestrooms, Bistro 300 and a commitment to excellent service. Make your reservation online at https://resweb.passkey.com/go/jhuoct2013 or call the hotel directly and specify that you are attending the Johns Hopkins Diabetic Retinopathy Conference to receive the special group rate of $189, single or double, plus tax. Complimentary round trip taxi vouchers and Wi-Fi in the guest rooms are included in this special rate. On-site parking is available at an additional charge. Check-in time is 4:00 p.m. Check out time is 12:00 noon. Evaluation A form will be available to attendees to evaluate each session and each speaker’s presentation, as well as to identify future educational needs. Outcomes Survey A survey will be sent to all physician attendees within three months post activity to assist us in determining what impact this activity had on the attendee’s practice. Emergency Calls On October 11, 2013 direct emergency calls to the Hopkins registration desk, (410) 955-3673. Messages will be posted for participants. Americans with Disabilities Act The Johns Hopkins University School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs. To Register or For Further Information Register Online (credit card and eCheck) www.HopkinsCME.edu Register by Phone (credit card only) (410) 502-9635 Register by Fax (866) 510-7088 Confirmation/Certificates (410) 502-9635 General Information (410) 955-2959 E-mail the Office of CME cmenet@jhmi.edu Follow us on Twitter: http://twitter.com/HopkinsCME Facebook: http://www.facebook.com/HopkinsCME Visit the Wilmer Eye Institute website at www.wilmer.jhu.edu For general information, the direct link for this CME activity web page is: http://www.hopkinscme.edu/CourseDetail.aspx/80031997 Acknowledgement Applications for commercial support from health care related industries are pending. A complete list of contributors will be provided in the syllabus. Registration Form Course Number 80031997 What’s New In Diabetic Retinopathy and Venous Occlusive Disease October 11, 2013 To Register:   Online (credit card and eCheck): www.HopkinsCME.edu By fax: (866) 510-7088    By phone (credit card only): (410) 502-9635 Or mail this form to the Johns Hopkins University, Office of Continuing Medical Education, P.O. Box 64128, Baltimore, Maryland 21264-4128. Include check payable to HOPKINS/80031997, or include credit card information below. PAYMENT MUST ACCOMPANY FORM TO CONFIRM YOUR REGISTRATION. M I am a Johns Hopkins speaker for this activity. Please type or print clearly: last name first name m.i. highest degree primary specialty Hopkins Faculty/Staff Only – JHED ID: mailing address city state ZIP + 4 code country daytime telephone fax number e-mail / / / / / / / / / / / / / / / / / / / / / / You will receive a confirmation notice and your attendance certificate by e-mail if you provide your e-mail address. M Check here if you wish to receive e-mail notices about upcoming CME activities. What do you hope to learn by attending this activity? ____________________________________________________________________ Please notify us if you have any special needs. ____________________________________________________________________ Registration Fees: On or Before September 3 M Physicians/Allied Health Professionals........................................................$275 M Residents*/Fellows*......................................................................................$175 After September 3 M Physicians/Allied Health Professionals........................................................$325 M Residents*/Fellows*......................................................................................$225 *with verification of status For registrations received after 5:00 p.m. EST on October 4, 2013, include a $50 late fee. On-site registrations are payable only by credit card. Total amount enclosed $_____________ Payment Type: JHU Faculty/Staff Only: If you are using your Tuition Remission Benefit or an ION budget, please complete this registration form and return with appropriate payment processing form to OCME, Turner 20. Forms can be found on-line at: http://www.hopkinscme.edu/Resources/resources.aspx. M Check (See instructions on top of form.) M Credit Card:  M VISA   M MASTERCARD   M DISCOVER   M AMEX Card # __ __ __ __ - __ __ __ __ - __ __ __ __ - __ __ __ __ Exp. Date__________ Name on Card Signature and Date

×